BridgeMD
New treatment option for Lacunar Stroke
Official title Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD)
ClinicalTrials.gov ID: NCT06525987
What this study is testing
- What it's testing
- The TELECONNECT-SVD study is a prospective, randomized, multicenter trial aimed at testing the efficacy of a remotely delivered exercise protocol on brain functional connectivity in patients with small vessel disease (SVD)-related ischemic stroke. The study will recruit patients aged ≥60 with a history of lacunar stroke, minimal disability (modified Rankin Scale score 0-1), and low physical activity levels.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Age ≥60 years;
- History of lacunar stroke occurred between 3 months and 10 years from screening and confirmed by neuroimaging or clinical data by an expert stroke...
- Modified Rankin Scale (mRS) score of 0-1, indicating no symptoms or no significant disability;
- A level of physical activity below recommended targets, i.e. \<150 minutes per week of moderate-to-vigorous exercise (24);
- Ability to sign informed consent.
You likely can't join if
- Uncontrolled hypertension;
- Heart disease impairing the possibility of safely following an exercise protocol at the discretion of the treating physician;
- Primary or secondary epilepsy;
- Prostheses, implants, and any device that might impair the performance of either high-density electroencephalogram or the exercise intervention;
- Cognitive impairment (Mini Mental State Examination score ≤26 at follow-up);
- Lack of access to Internet-based facilities or poor technological alphabetization impairing the adherence to the trial protocol;
See the full eligibility criteria
- Age ≥60 years;
- History of lacunar stroke occurred between 3 months and 10 years from screening and confirmed by neuroimaging or clinical data by an expert stroke physician;
- Modified Rankin Scale (mRS) score of 0-1, indicating no symptoms or no significant disability;
- A level of physical activity below recommended targets, i.e. \<150 minutes per week of moderate-to-vigorous exercise (24);
- Ability to sign informed consent.
- Uncontrolled hypertension;
- Heart disease impairing the possibility of safely following an exercise protocol at the discretion of the treating physician;
- Primary or secondary epilepsy;
- Prostheses, implants, and any device that might impair the performance of either high-density electroencephalogram or the exercise intervention;
- Cognitive impairment (Mini Mental State Examination score ≤26 at follow-up);
- Lack of access to Internet-based facilities or poor technological alphabetization impairing the adherence to the trial protocol;
- Any major physical or psychiatric comorbidity that in the judgement of the treating physician might compromise the ability to undergo an exercise intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Avezzano, L'Aquila, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Avezzano, L'Aquila, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.